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The mechanisms that govern the maintenance and
differentiation of tissue-specific progenitors in devel-
opment and tissue regeneration are poorly under-
stood. We show that development of Sox2+ progen-
itors in the lung endoderm is regulated by histone
deacetylases 1 and 2 (Hdac1/2). Hdac1/2 deficiency
leads to a loss of Sox2 expression and a block in
proximal airway development. This is mediated in
part by derepression of Bmp4 and the tumor
suppressor Rb1, which are direct transcriptional
targets of Hdac1/2. In contrast to development, post-
natal loss of Hdac1/2 in airway epithelium does not
affect the expression of Sox2 or Bmp4. However,
postnatal loss of Hdac1/2 leads to increased expres-
sion of the cell-cycle regulators Rb1, p21/Cdkn1a,
and p16/Ink4a, resulting in a loss of cell-cycle
progression and defective regeneration of Sox2+
lung epithelium. Thus, Hdac1/2 have both common
and unique targets that differentially regulate
tissue-specific progenitor activity during develop-
ment and regeneration.
INTRODUCTION
Many tissues contain resident progenitor populations that are
critical for both development and postnatal repair and regenera-
tion. The foregut endoderm is amultipotent tissue that generates
multiple organs during development, including the lung, thyroid,
liver, and pancreas. Sox2 is expressed in the developing foregut
endoderm, and lineage-tracing experiments have demonstrated
that Sox2+ cells can act as tissue-specific progenitors in several
tissues, including the lung, stomach, and testes (Arnold et al.,
2011). Accumulating evidence also points to the functional
importance of Sox2 in regulating tissue-specific progenitor cells
during both development and adult homeostasis. Ablation ofDevelopmSox2-expressing cells in the adult disrupts tissues homeostasis
leading to multiorgan failure and lethality (Arnold et al., 2011).
However, the mechanisms regulating maintenance and differen-
tiation of Sox2+ progenitors during development and tissue
regeneration is poorly understood.
In addition to direct control of cell fate decisions by DNA
binding transcription factors, epigenetic regulation of gene
expression is also important for integrating signaling input and
transcriptional output during development (Xu et al., 2011).
Histone deacetylases (Hdacs) play an important role in regu-
lating chromatin compaction through deacetylation of histones,
which counterbalances the action of histone acetyltransferases
(HATs). Although many Hdacs are widely expressed, little is
known about their direct transcriptional targets and how they
regulate tissue-specific gene expression. In the lung, decreased
expression of HDAC2 has been associated with chronic obstruc-
tive pulmonary disease (COPD), a broad disease spectrum that
leads to the irreversible loss of airway and alveolar structure
and function and is thought to be due to a chronically defective
injury-regeneration cycle caused by environmental insults (Ito
et al., 2005, 2006). However, little is known about the roles of
chromatin remodeling complexes, including Hdac1/2, in either
lung development or postnatal homeostasis and regeneration.
In this report, we show that Hdac1/2 are necessary for Sox2
gene expression, which in turn, is required for the development
of the proximal airways of the lung. The loss of Sox2 expression
is caused, in part, by the derepression of Bmp4 expression,
a direct target gene of Hdac1/2. Increased Bmp4 expression
leads to decreased Sox2+ proximal progenitors and an expan-
sion of Sox9+/Id2+ distal progenitors in the developing lung,
resulting in a failure to form proximal airways in the lung.
Importantly, reduction of Bmp4 expression partially rescues
Sox2 expression in vivo during development. We also show
that Rb1 is a direct target of Hdac1/2-mediated repression and
loss of Hdac1/2 leads to derepression of Rb1 and inhibition of
cell-cycle progression. In the postnatal lung, airway epithelial
loss of Hdac1/2 expression does not lead to Bmp4 derepression
or changes in homeostatic Sox2 expression. However, in a
model of airway injury and regeneration, loss of Hdac1/2 expres-
sion derepresses Rb1 expression, along with p21/Cdkn1a andental Cell 24, 345–358, February 25, 2013 ª2013 Elsevier Inc. 345
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Figure 1. Loss of Hdac1/2 Disrupts Lung Endoderm Development
but Not Endoderm Identity
(A–F) Hdac1 is expressed broadly throughout the lung endoderm and
mesenchyme from E12.5 through E17.5 (A–C). Hdac2 is initially expressed in
both lung endoderm andmesenchyme at E12.5 (D) but becomes progressively
restricted to proximal airway epithelium by E17.5 (E and F, arrows).
(G–L) Hdac1/2ShhcreDKO mutants lack epithelial expression of Hdac1 and
Hdac2 from E12.5 through E17.5 (arrowheads). Dotted lines outline the
developing airway epithelium.
(M–S) In comparison to control littermates (M–O), Hdac1/2ShhcreDKO mutants
display defects in airway branching as exhibited by the formation of cysts in the
lung at E12.5 (P), and these cysts expand in later development, resulting in an
overall smaller lung (Q–S, arrowheads).
(T–W) Hdac1/2ShhcreDKO mutants maintain proper lung and esophagus spec-
ification as noted by Nkx2.1 and p63 immunostaining at E11.5 (T and U). Lung
endoderm identity is maintained through development as noted by continuous
expression of Nkx2.1 (V and W).
BV, blood vessel; E, esophagus; T, trachea. Scale bars represent 20 mm in
(J)–(L), (U), and (W) and 40 mm in (P)–(R). See also Figure S1.
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HDAC1/2 Control Lung Development and Regenerationp16/Ink4a, leading to a persistent loss of Sox2+ epithelial cell
regeneration after injury. These data show that Sox2+ progeni-
tors in the lung are regulated by Hdac1/2 during development
and regeneration through derepression of Bmp4 and Rb1 in
a stage-specific fashion, providing a differential role for
chromatin remodeling factors in endoderm development and
regeneration.
RESULTS
Expression of Hdac1/2 during Lung Development
To determine the expression pattern of Hdac1/2 in lung develop-
ment, we performed immunohistochemistry on embryonic lung346 Developmental Cell 24, 345–358, February 25, 2013 ª2013 Elsevsections for Hdac1/2 protein expression at various stages of
gestation. Beginning at E12.5, both Hdac1 and Hdac2 are widely
expressed in both the endoderm and mesenchyme of the devel-
oping lung (Figures 1A and 1D). Hdac1 continues to be broadly
expressed at later stages in both the endoderm and mesen-
chyme of the lung (Figures 1B and 1C). In contrast, Hdac2
expression decreases in the mesenchyme after E12.5 and is
expressed primarily in proximal airway epithelium by E17.5
(Figures 1E and 1F). Hdac2 expression was detected in both
secretory cells and ciliated cells in the adult lungs (Figures
S1M–S1P available online). These data indicate that the expres-
sion patterns of Hdac1 and Hdac2 overlap during lung develop-
ment and suggest that the both factors may play an important
role in regulating proximal airway endoderm development.
Loss of Hdac1/2 Expression Leads to Defective Lung
Development
To determine the importance of Hdac1/2 in lung development,
we generated a foregut endoderm-specific deletion of these
genes using Hdac1flox/flox andHdac2flox/flox alleles and the Shhcre
line, which efficiently drives cre recombination in the early ante-
rior foregut endoderm beginning at approximately E8.75 (Goss
et al., 2009; Montgomery et al., 2007). These mutants will now
be referred to as Hdac1/2ShhcreDKO. Hdac1 and Hdac2 were effi-
ciently deleted in the mutant lung epithelial cells from E12.5 and
later (Figures 1G–1L). Hdac1/2ShhcreDKO mutants all died at birth
because of respiratory distress (data not shown), and examina-
tion of lungs from E17.5 Hdac1/2ShhcreDKO mutants showed
a severe loss of branching morphogenesis, resulting in large
dilated sac-like structures instead of well-formed lung lobes
(Figures 1R and 1S). To assess the chronological onset of these
defects, we examined Hdac1/2ShhcreDKO lungs and controls at
E10.5 and E12.5. At E10.5, the trachea of Hdac1/2ShhcreDKO
mutants had separated from the esophagus, and the first
branching event that generates the main stem bronchi had
occurred normally (Figures S1A–S1F). However, although
control lungs had begun to branch extensively by E12.5,
Hdac1/2ShhcreDKO mutant lungs exhibited a severe inhibition of
branching (Figures 1M and 1P). This defect in branching
morphogenesis was also obvious at E14.5 (Figures 1N and
1Q). Of note, individual loss of either Hdac1 or Hdac2 did not
result in obvious defects in lung morphogenesis, and these
mutants were viable (data not shown), which indicates that
Hdac1 and 2 are redundantly required for lung development.
To determine whether normal tracheal specification had
occurred in Hdac1/2ShhcreDKO mutants, expression of Nkx2.1,
amarker of the early respiratory endoderm, including the trachea
and p63, which is expressed preferentially in the esophagus at
this stage, was examined by immunohistochemistry at E11.5.
Supporting the histological data, the trachea in both control
and Hdac1/2ShhcreDKO mutants expressed Nkx2.1, whereas the
esophagus in both control and Hdac1/2ShhcreDKO mutants ex-
pressed p63 (Figures 1T and 1U). Nkx2.1 continued to be ex-
pressed in the abnormal lung epithelium of Hdac1/2ShhcreDKO
mutants at E17.5 (Figures 1V and 1W), suggesting that lung
epithelial identity is maintained throughout development. These
data indicate that loss of Hdac1/2 in the lung endoderm leads to
defects in early lung branching morphogenesis but not respira-
tory specification or separation of the trachea and esophagus.ier Inc.
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Development
To assess the molecular consequences from loss of Hdac1/2 in
early lung endoderm, microarray analysis was performed on
control and Hdac1/2ShhcreDKO mutant lungs at E12.5. We found
that 149 genes were downregulated, and 70 genes were upregu-
lated more than 1.4-fold in Hdac1/2ShhcreDKO mutant lungs (see
Table S1). A focused examination of changes in transcription
factor gene expression showed that the expression level of
Sox2 was decreased in Hdac1/2ShhcreDKO mutant lungs (Fig-
ure 2A). The developing airways of the lung are patterned in
a distinct proximal-distal manner with Sox2 expression marking
the proximal airway progenitor population that will generate
most if not all of the epithelial lineages within the trachea and
bronchi (Arnold et al., 2011; Que et al., 2007; Sommer et al.,
2009; Tompkins et al., 2009, 2011). Conversely, Sox9 and Id2
mark distal endoderm progenitors in the early lung (Rawlins
et al., 2009). Although Sox9+/Id2+ distal progenitors aremultipo-
tent prior to E13.5, their progenitor capacity is restricted to
generating distal alveolar epithelial lineages after this time point
(Rawlins et al., 2009) (Figure 2B).
Immunostaining of a series of histological sections from the
anterior to posterior regions of both control and Hdac1/
2ShhcreDKO lungs showed a significant loss of Sox2 protein
expression at E12.5 (Figure 2C). This was confirmed by quantita-
tive real-time PCR (Figure 2D). At E10.5, a small number of
Sox2+ cells were observed in the dorsal aspect of the developing
trachea in both control and Hdac1/2ShhcreDKO mutant lungs,
although the number of Sox2+ cells appeared slightly reduced
in the Hdac1/2ShhcreDKO mutants (Figures S1C and S1F). This is
likely due to the incomplete loss of Hdac1/2 protein prior to
E11.5 (Figures S1A, S1B, S1D, and S1E), despite the fact that
Shhcre-driven recombination is observed as early as E8.75
(Goss et al., 2009). Of note, Hdac1/2 were also efficiently deleted
in the developing esophageal endoderm using the Shhcre line
(Figures S1G–S1J), yet Sox2 expression did not appear to be
affected in the esophagus (Figures S1K and S1L). These data
show that Hdac1/2 are required for Sox2 expression in the devel-
oping lung endoderm but not in the esophagus.
To determine whether distal progenitor development was dis-
rupted in the Hdac1/2ShhcreDKO mutant lungs, we examined the
expression of Sox9 by immunostaining. Sox9 expression was
expanded throughout both the proximal and distal regions of
Hdac1/2ShhcreDKO mutant lungs (Figure 2E). Quantitative real-
time PCR showed that levels of Sox9 expression in the whole
lung were not significantly altered in HDAC1/2ShhcreDKO mutant
lungs (Figure 2F), possibly because of decreased Sox9 expres-
sion on a per cell basis in Sox9+ cells or decreased mesen-
chymal Sox9 expression, which masked the increased Sox9
expression in the epithelium. In contrast, expression of the distal
progenitor marker Id2 was both expanded and increased in
Hdac1/2ShhcreDKO mutant lungs as shown by both in situ and
quantitative real-time PCR (Figures 2F and S2A). These data
suggest a critical role for Hdac1/2 in regulating the balance
between proximal and distal progenitors during early lung
development.
Previous studies have shown that Sox2 is a crucial regulator of
proximal endoderm lineage identity and differentiation in the lung
(Que et al., 2007, 2009; Tompkins et al., 2009, 2011). To assessDevelopmwhether Hdac1/2ShhcreDKO mutant lungs exhibited defects in
proximal cell fate development and differentiation, we examined
the expression of early lung proximal progenitor markers SSEA1
(also known as Fut4) and Scgb3a2. Expression of both of these
markers was decreased in Hdac1/2ShhcreDKO mutant lungs
(Figures 2G–2J). Additional differentiation markers of proximal
cell lineages, including Scgb1a1 (secretory Clara cells), beta-
Tubulin IV (ciliated epithelial cells), and Ascl1 (neuroendocrine
cells), were all greatly reduced or undetectable in Hdac1/
2ShhcreDKO mutant lungs (Figures 2K–2N and S2D–S2G). Expres-
sion of the goblet cell marker gene Clca3 was not changed in
Hdac1/2ShhcreDKO mutant lungs (Figures S2H and S2I). In
contrast, distal lineage markers, including T1alpha (alveolar
type I cells) and Sftpc (alveolar type II cells), were still present
in the mutant lungs (Figures 2M and S2C), suggesting that distal
epithelial lineage differentiation is not dramatically affected in
these mutants.
Hdac1/2 Directly Regulates Bmp4 Expression to Control
Proximal Lung Endoderm Progenitor Development
The loss of Sox2+ progenitors in the lung and not in the esoph-
agus suggested a specific role for Hdac1/2 in regulating Sox2
expression in the proximal airways of the lung. Little is under-
stood about the molecular pathways essential for development
and differentiation of Sox2+ progenitors. Therefore, we exam-
ined expression of multiple pathways known to regulate early
lung progenitor specification and differentiation, with a focus
on those that are regulators of proximal-distal progenitor differ-
entiation (Domyan et al., 2011; Goss et al., 2009; Izvolsky
et al., 2003; Park et al., 1998; Shu et al., 2005; Tsao et al.,
2009; Weaver et al., 1999, 2000; Yin et al., 2008). These studies
revealed that Bmp4 expression was significantly upregulated in
Hdac1/2ShhcreDKO mutants (Figure 3A). In situ hybridization
showed that Bmp4 expression was expanded throughout the
early endoderm of Hdac1/2ShhcreDKOmutants (Figure 3B) instead
of being confined to the endoderm at the distal tip of the branch-
ing airways as observed in the control lungs and as has been
previously reported (Weaver et al., 1999, 2000). Expression of
members of the Wnt and Fgf pathways and the downstream
effectors of these pathways were not significantly altered in
Hdac1/2ShhcreDKO mutants. Expression of Notch1 was slightly
upregulated, whereas expression of the Notch effector Hes1
was slightly downregulated. However, such minor and inconsis-
tent alterations in expression of Notch signaling components
suggests that Notch is not significantly disrupted in Hdac1/
2ShhcreDKO mutants.
Bmp signaling is an important regulator of anterior foregut
endoderm development as well as a regulator of proximal-distal
patterning of the developing lung. Inhibition of Bmp signaling
through overexpression of the Bmp antagonists noggin or
gremlin inhibits distal lung development and expands proximal
lung development (Lu et al., 2001; Weaver et al., 1999). How
Bmp signaling regulates the balance between proximal and
distal lung development is unclear, and whether it affects early
progenitor specification, maintenance, or differentiation has
not been assessed. To determine whether increased Bmp4
expression could alter the balance between proximal (Sox2+)
and distal (Sox9+) lung progenitors, E11.5 lung explants were
treated with exogenous Bmp4 for 48 hr. Exogenous Bmp4ental Cell 24, 345–358, February 25, 2013 ª2013 Elsevier Inc. 347
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Figure 2. Hdac1/2 Are Required for Development of Sox2+ Proximal Lung Endoderm Progenitors
(A) The heatmap generated frommicroarray results shows differential expression of 42 transcription factors in the Hdac1/2ShhcreDKOmutants compared to Shhcre
controls, including Sox2.
(B) This scheme shows the relative spatial distribution of Sox2+ proximal lung endoderm progenitors (green) and Sox9+/Id2+ distal lung progenitors (red).
(C) Immunostaining of sections throughout the anterior to posterior regions of the lung shows that Hdac1/2ShhcreDKO mutants have a dramatic loss of Sox2
expression at E12.5. The scheme on the right demonstrates the approximate positions of cross-sections along the anterior-posterior axis of the lung buds. The
green color outlines the Sox2 expression pattern in control and Hdac1/2ShhcreDKO mutants.
(D) Quantitative real-time PCR results confirm the loss of Sox2 expression in Hdac1/2ShhcreDKO mutants at E12.5.
(legend continued on next page)
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HDAC1/2 Control Lung Development and Regenerationcaused a decrease in both the expression and number of Sox2+
cells in the lung (Figure 3C). This decrease resulted in inhibition of
proximal airway endoderm development as noted by decreased
Scgb3a2 and SSEA1 expression (Figure 3C). In contrast,
exogenous Bmp4 treatment expanded the number of Sox9+
progenitors such that they were observed in the proximal
airways of the treated lungs (Figure 3C). Moreover, Id2 expres-
sion was increased by Bmp4 treatment, which is consistent
with Id2 as a direct target of Bmp signaling and amarker of distal
lung endoderm progenitors (Figure 3C). Of note, these changes
in gene expression and spatial localization of Sox9+ cells were all
similar to what was observed in Hdac1/2ShhcreDKO mutants
(Figure 2).
Previous studies have shown that increased Bmp4 expression
increases apoptosis in multiple tissues, including the lung
(Bellusci et al., 1996). Hdac1/2ShhcreDKO mutant lungs exhibited
an increase in apoptosis from E11.5 through E14.5 as noted by
increased activated caspase-3 immunostaining (Figures S3A
and S3B). Treatment of wild-type lung explants with exogenous
Bmp4 also increased apoptosis (Figures S3C and S3D). As in
Hdac1/2ShhcreDKO mutant lungs, this increase in apoptosis was
not spatially restricted and was observed throughout the endo-
derm of the treated explants (data not shown).
To determine whether Bmp4 was a direct target of Hdac1/2 in
the developing lung, chromatin immunoprecipitation (ChIP)
assays were performed on the Bmp4 promoter region using
Hdac1/2 antibodies. These experiments showed robust binding
of Hdac1/2 to the proximal promoter region of Bmp4 at E12.5
(Figures 3D and 3E; data not shown). In contrast, Hdac1 and
Hdac2 binding was not observed in an unrelated intergenic
region 1.5 megabases upstream of the Bmp4 locus (Figure 3D).
To assess whether the loss of Hdac1/2 altered the acetylation
state of histones on the Bmp4 promoter in lung epithelial cells,
Hdac1/2 expression was knocked down in the lung epithelial
cell line MLE12 (Figure 3F) (Wikenheiser et al., 1993). Loss of
Hdac1/2 expression led to increased H3K9 acetylation on the
Bmp4 promoter (Figure 3G), whereas acetylation was unaffected
in an unrelated intergenic region upstream of Bmp4 (Figure 3H).
Similarly, treatment of lung explants with the Hdac inhibitor
trichostatin A (TSA) resulted in an elevated level of H3K9 acety-
lation at the Bmp4 promoter (Figure 3I), without altering the
acetylation level at the intergenic region (Figure 3J). Together,
these data indicate that Bmp4 is a direct target of Hdac1/2
during lung endoderm development and its derepression leads
to downregulation of Sox2 expression, expansion of Sox9+/
Id2+ progenitors, and increased endoderm apoptosis.
To determine if reducing the dose of Bmp4 would partially
rescue the loss of Sox2 expression in Hdac1/2ShhCreDKO
mutants, we deleted one copy of Bmp4 in the Hdac1/2ShhCreDKO(E) Hdac1/2ShhcreDKO mutants have expanded Sox9 expression throughout the d
approximate positions of cross-sections along the anterior-posterior axis of the
Hdac1/2ShhcreDKO mutants.
(F) Quantitative real-time PCR shows that although overall expression levels of So
Hdac1/2ShhcreDKO mutants.
(G–N) Expression of the early proximal epitheliummarker SSEA1 (Fut4) (G and I), s
(K and M, green), and markers of the ciliated epithelial lineage, including Tubb
mutants. In contrast, expression of the alveolar type 2 cell marker Sftpc is still no
White dotted lines mark the boundary between epithelium and mesenchyme in (C
assays ± SEM. Eso, esophagus. Scale bars represent 20 mm in (C), (E), (I), (M), a
Developmmutants using a floxed allele of Bmp4 (Kulessa and Hogan,
2002). We then performed immunohistochemistry for Sox2 in
the Hdac1/2ShhCreDKO:Bmp4D/+ lungs at E12.5 to assess the
expression of Sox2. Although Sox2 expression was not detect-
able in any of the Hdac1/2ShhCreDKO lungs we have examined
(n = 7), we found that 50% of Hdac1/2ShhCreDKO:Bmp4D/+ lungs
(n = 6) showed partial restoration of Sox2 expression in the
bronchi and airway epithelium upon deletion of one copy of
Bmp4 (Figures 3K–3P). Epithelial apoptosis was also reduced
in the Hdac1/2ShhCreDKO:Bmp4D/+ lungs (Figures S3E and S3F).
Overall lung structure, however, was not fully restored although
additional branch points were evident in a subset of the
compound mutant lungs (Figures S3G–S3K). These studies
suggest that Hdac1/2 are required to suppress Bmp4 in the
proximal lung endoderm to allow for proper airway development.
Given the lack of a more robust rescue, these data also suggest
that additional molecular pathways are responsible for some
aspects of the phenotype observed in Hdac1/2ShhCreDKO
mutants.
Endoderm Progenitor Proliferation Is Mediated in Part
by Hdac1/2 Repression of Rb1
Previous studies have shown that a common effect of the
combined loss of Hdac1/2 expression is decreased cell prolifer-
ation coupled with increased apoptosis (LeBoeuf et al., 2010; Ma
et al., 2012; Montgomery et al., 2007). Decreased proliferation
was observed in Hdac1/2ShhcreDKO mutant lungs as shown by
phospho-histone H3 staining, and the decrease in proliferation
was uniform throughout the mutant lungs (Figure 4A). Several
important regulators of the cell cycle, including p16/Ink4a and
p21/Cdkn1a, have been shown to be direct targets of Hdac1/
2-mediated repression (Lagger et al., 2002, 2003; Wilting et al.,
2010; Yamaguchi et al., 2010). However, loss of p16/Ink4a or
p21/Cdkn1a does not rescue Hdac1/2-mediated inhibition of
cell proliferation, suggesting the importance of additional targets
of Hdac1/2 in regulating cell-cycle progression (Wilting et al.,
2010). Therefore, we examined our microarray data for changes
in expression of cell-cycle regulators in Hdac1/2ShhcreDKO
mutants. In addition to increased expression of p21/Cdkn1a,
we observed increased expression of the tumor suppressor
retinoblastoma-1 (Rb1) in Hdac1/2ShhcreDKO mutant lungs (Fig-
ure 4C). Quantitative real-time PCR and immunostaining showed
that Rb1 as well as p16/Ink4a and p21/Cdkn1a were all
increased in Hdac1/2ShhcreDKO mutant lungs (Figures 4D–4J).
p57, another cell-cycle regulator that has been reported to be
a direct target of Hdac1/2, was not upregulated in the Hdac1/
2ShhcreDKO mutant lungs and was not expressed at significant
levels in the control lungs (data not shown; Yamaguchi et al.,
2010).ysmorphic airways (arrowheads). The scheme on the right demonstrates the
lung buds. The red color outlines the Sox9 expression pattern in control and
x9 are unchanged, expression of the distal progenitor marker Id2 is increased in
ecretory epithelium lineagemarkers, including Scgb3a2 (H and J) and Scgb1a1
IV (L and N, arrowhead), are lost or severely decreased in Hdac1/2ShhcreDKO
ted in Hdac1/2ShhcreDKO mutants (K and M, red).
) and (E). Quantitative real-time PCR data shown are the average of five to six
nd (N) and 40 mm in (J). See also Figure S2.
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Figure 3. Loss of Hdac1/2 Results in Increased Bmp4 Expression, which in Turn Represses Sox2 Expression in the Lung
(A) Quantitative real-time PCR analysis of major signaling pathway components in Hdac1/2ShhcreDKO mutants reveals a significant increase in Bmp4 expression.
(B) In situ hybridization shows increased and expanded Bmp4 expression throughout the entire dysmorphic lung endoderm of Hdac1/2ShhcreDKO mutants
(B, arrows).
(C) Treatment of lung explant cultures at E11.5 with recombinant Bmp4 (rBmp4) for 48 hr suppresses Sox2 expression (ii, arrowhead) and expands Sox9+ cells in
lung endoderm (iv, arrowheads). Note that Sox9 normally marks the distal lung epithelial progenitor cells (iii and iv, arrows) as well as proximal mesenchyme
(iii, arrowhead). In rBmp4-treated explants, Sox9 expression is expanded into the proximal airway epithelium of the lung explants (iv, arrowheads). Quantitative
real-time PCR shows decreased Sox2 expression along with a decrease in other early proximal epithelial markers, including Scgb3a2 and SSEA1 (Fut4), in
rBmp4-treated explants. Quantitative real-time PCR also shows increased expression of Id2 in rBmp4-treated lung explants. White dotted lines outline the distal
lung endoderm.
(D and E) ChIP assays using gel electrophoresis (D) and quantitative real-time PCR (E) show that Hdac1/2 directly bind to the Bmp4 promoter in the
E12.5 lung.
(legend continued on next page)
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HDAC1/2 Control Lung Development and RegenerationWe next tested whether Rb1 was a direct target of Hdac1/2 in
the lung. ChIP assays were performed using chromatin extracts
from E12.5 lungs. These studies showed that Hdac1/2 bound
robustly to the proximal promoter of Rb1 (Figures 4K and 4L).
siRNA-mediated knockdown of Hdac1/2 in MLE12 cells or TSA
treatment of lung bud explants resulted in increased H3K9 acet-
ylation at the Rb1 promoter (Figures 4M and 4N). Together with
the increase in Rb1 expression, these data indicate that Hdac1/2
are required to suppress Rb1 expression to allow for proper
proliferation of early lung endoderm. Thus, Hdac1/2 are potent
regulators of lung progenitor proliferation by targeting multiple
cell-cycle inhibitors in the developing lung, including Rb1, p16/
Ink4a, and p21/Cdkn1a.
Hdac1/2 Are Required for Regeneration but Not
Homeostasis of Lung Airway Epithelium
The effects of chromatin remodeling complexes and epigenetic
regulation on tissue regeneration are poorly understood. Given
the potent and specific roles for Hdac1/2 in regulating Sox2+
proximal endoderm progenitor development in the anterior
foregut, we assessed whether these factors were important
for proximal airway epithelial homeostasis and regeneration in
the postnatal lung. We generated Hdac1/2Scgb1a1creDKO mutants
using an Scgb1a1cre line, which is active in the proximal
airway secretory epithelium beginning at birth (Li et al., 2012).
Hdac1/2 were efficiently deleted in Hdac1/2Scgb1a1creDKO lungs
as shown by immunostaining 8-week-old mutant lungs (Figures
5A–5D). In contrast to deletion of Hdac1/2 during development,
loss of Hdac1/2 in proximal airway epithelium did not dramati-
cally affect postnatal airway epithelial homeostasis as noted
by the normal appearance of the airway epithelium and expres-
sion of markers for secretory and ciliated epithelial lineages in
Hdac1/2Scgb1a1creDKO mutants (Figures 5E–5M). Proliferation
and apoptosis was also not affected in Hdac1/2Scgb1a1creDKO
mutants (data not shown). Importantly, expression of Sox2,
which is expressed in the postnatal secretory lineage, was not
altered in the lungs of Hdac1/2Scgb1a1creDKO mutants (Figures
5G, 5K, and 5M). Thus, Hdac1/2 are not required for postnatal
airway epithelial cell homeostasis.
The lung has a remarkable capacity to regenerate epithelial
lineages, including the secretory cells within the proximal
airways after injury. To determine whether expression of
Hdac1/2 were important for airway epithelial regeneration, we
used a model of airway secretory cell depletion caused by naph-
thalene exposure. Napthalene injury depletes the vast majority of
airway secretory cells (also called Clara cells) in the postnatal
lung, and the airway epitheliumwill regenerate through a process
involving expansion and differentiation of a small subset of naph-
thalene-resistant secretory cells often referred to as facultative
airway progenitors (Giangreco et al., 2002) (Figure 6A). Hdac1/
2Scgb1a1creDKO mutant and Scgb1acre control mice were treated
with naphthalene, and the epithelial regeneration process was(F–H) MLE12 cells were transfected with Hdac1/2 or control siRNAs to effectivel
H3K9 acetylation level at the Bmp4 promoter after Hdac1/2 knockdown (G), whe
(I–J) TSA treatment of E11.5 lung explants results in an increased level of H3K9
(K–P) Loss of one copy of Bmp4 partially rescues Sox2 expression in the Hdac1
Quantitative real-time PCR and ChIP PCR data shown are the average of three to
(P). See also Figure S3.
Developmassessed at multiple time points using immunostaining and
quantitative real-time PCR for Scgb1a1 (secretory cells), beta-
Tubulin IV (TubbIV) (ciliated cells), and Sox2, which marks both
secretory cells and a significant proportion of ciliated cells in
the adult airway. Four days after injury, the majority of secretory
cells in both Hdac1/2Scgb1a1creDKO and control lungs were
depleted as shown by the dramatic decrease in Scgb1a1 and
Sox2 expression (Figures 6B–6E). Ten days postinjury, although
a significant recovery in the number of secretory cells was
observed in Scgb1a1cre control lungs, Hdac1/2Scgb1a1creDKO
mutants displayed a dramatic inhibition in regeneration of
Scgb1a1+/Sox2+ secretory cells after injury (Figures 6F and
6G). Examination of Hdac1/2Scgb1a1creDKO mutant lung airways
using hematoxylin and eosin staining (H&E) staining showed
that they lacked extensive repopulation of secretory cells
10 days after injury, in contrast to control airways, which had
begun to repopulate with secretory epithelium. These alterations
in Scgb1a1+/Sox2+ cells were also observed at 1 month after
injury, suggesting that the loss of regeneration is persistent
and not transient (Figures 6H and 6I). Beta-tubulin IV expression
showed a slight decrease in ciliated cells in the mutant lungs by
quantitative real-time PCR at 10 days postinjury and normal
expression level at 1 month, consistent with the fact that naph-
thalene specifically depletes the secretory lineage (Figures
6F–6I). Sox2 expression in ciliated cells was decreased in the
Hdac1/2Scgb1a1creDKO mutants both at 10 days and 1month after
injury (Figures S4A–S4F), further exacerbating the overall
decrease in Sox2 expression in these mutants. Goblet cell
markers Mucin5ac and Agr2 were not changed in the Hdac1/
2Scgb1a1creDKO mutant lungs prior to or during the regeneration
process, indicating a lack of an effect on goblet cell differentia-
tion in these mutants (Figures S4G–S4M).
Given the critical roles of Hdac1/2 in regulating Bmp4 expres-
sion and cell-cycle progression during lung development
through repression of Rb1, p16/Ink4a, and p21/Cdkn1a, we
tested whether Hdac1/2 regulated these cellular pathways
during adult regeneration. Quantitative real-time PCR and
in situ hybridization did not reveal changes in Bmp4 expression
in HDAC1/2Scgb1a1creDKO lungs (Figure S5; data not shown). In
contrast, proliferation of regenerating airway epithelium of
Hdac1/2Scgb1a1creDKO mutant lungs was significantly compro-
mised during the course of regeneration, especially between
day 4 and day 10 postinjury, when the naphthalene-resistant
facultative progenitors expand to regenerate the airway epithe-
lium (Figures 7A and 7B). This decrease in proliferation was
associated with an increase in the cell-cycle inhibitors Rb1,
p21/Cdkn1a, and p16/Ink4a at day 7 after injury (Figures 7C–
7H). Of note, expression of these proteins was not altered in
HDAC1/2Scgb1a1creDKO lungs prior to injury (Figure S5), suggest-
ing that Hdac1/2 regulation of Rb1, p21/Cdkn1a, and p16/Ink4a
is only reactivated during the regeneration process. These data
indicate that Hdac1/2 regulate lung endoderm developmenty and specifically inhibit Hdac1/2 expression (F). ChIP assays show increased
reas an intergenic region upstream of Bmp4 is not affected (H).
acetylation at the Bmp4 promoter (I) but not the intergenic region (J).
/2ShhcreDKO mutants (arrowheads, compare M and P).
five assays ± SEM. Scale bars represent 20 mm in (B), (C), and (H) and 40 mm in
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Figure 4. Rb1 Is a Direct Target of Hdac1/2 Repression
(A and B) Phospho-histone H3 (PO4-H3) immunostaining shows that proliferation is decreased throughout Hdac1/2ShhcreDKO mutant lung endoderm.
(C) Heatmap of genes associated with cell proliferation from Hdac1/2ShhcreDKO mutants shows increased expression of Rb1 and p21/Cdkn1a.
(D–I) Immunostaining for Rb1, p16/Ink4a, and p21/Cdkn1a demonstrates that these cell-cycle inhibitors are undetectable in control lungs at E12.5 but are
induced in Hdac1/2ShhcreDKO mutants.
(J) Quantitative real-time PCR confirms the derepression of Rb1 and p21/Cdkn1a transcripts at E12.5 in Hdac1/2ShhcreDKO mutants.
(K and L) ChIP assays using gel electrophoresis (K) and quantitative real-time PCR (L) show that Hdac1/2 binds robustly to the Rb1 proximal promoter in
E12.5 lungs.
(M and N) Hdac1/2 knockdown in MLE12 cells (M) or treating lung bud explants with TSA (N) increases the H3K9 acetylation level at the Rb1 promoter.
Quantitative real-time PCR and ChIP PCR data shown are the average of three to five assays ± SEM. Scale bars represent 20 mm in (A) and 10 mm in (D)–(I).
Developmental Cell
HDAC1/2 Control Lung Development and Regeneration
352 Developmental Cell 24, 345–358, February 25, 2013 ª2013 Elsevier Inc.
00.2
0.4
0.6
0.8
1
1.2
1.4
1.6
Scgb1a1 Sox2 Scgb3a2 
Ctrl
Scgb1a1cre DKO
H
da
c1
H
da
c2
H&E Scgb1a1 Sox2 TubbIV
re
la
tiv
e 
ex
pr
es
si
on
Hdac1/2Scgb1a1creDKO Hdac1/2Scgb1a1creDKO
H
da
c1
/2
Sc
gb
1a
1c
re
D
K
O
C D
E
I
A B
F G H
J K L
M
control control
co
nt
ro
l
Figure 5. Loss of Hdac1/2 Expression Does Not Disrupt Postnatal Airway Epithelial Homeostasis
(A–D) Hdac1 (A and B) and Hdac2 (C and D) expression are significantly reduced in the airway epithelium of Hdac1/2Scgb1a1creDKO mutants compared to
Scgb1a1cre controls.
(E–L) Loss of Hdac1/2 expression in Hdac1/2Scgb1a1creDKO mutants does not disrupt airway epithelial morphology by H+E staining (E and I). Loss of Hdac1/2
expression in Hdac1/2Scgb1a1creDKO mutants does not disrupt expression of secretory cell markers Scgb1a1 (F and J) and Sox2 (G and K). Loss of Hdac1/2
expression does not disrupt expression of the ciliated epithelial marker TubbIV (H and L).
(M) Quantitative real-time PCR shows only a minor loss of expression for the secretory marker genes Scgb1a1 and Scgb3a2 and no significant change in Sox2
expression in Hdac1/2Scgb1a1creDKO mutants.
Quantitative real-time PCR data shown are the average of three to five assays ± SEM. Scale bars represent 20 mm.
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and the cell-cycle regulators Rb1, p16/Ink4a, and p21/Cdkn1a.
DISCUSSION
In these studies, we show that the expression of the critical tran-
scription factor Sox2 is regulated in the anterior foregut through
the chromatin remodeling factors Hdac1/2. Development of the
proximal Sox2+ endoderm progenitors in the lung requires
Hdac1/2 expression via regulation of Bmp4 signaling as well as
cell-cycle progression through Rb1, p16/Ink4a, and p21/
Cdkn1a. Derepression of Bmp4 expression leads to loss of
Sox2+ proximal endoderm progenitors in the lung along with
the subsequent failure to form the proximal airways during devel-
opment. In contrast to development, Hdac1/2 regulate regener-
ation of Sox2+ airway secretory cells through repression of
a cell-cycle program, including Rb1, p16/Ink4a, and p21/
Cdkn1a, without affecting Bmp4 expression. These studies
show that Sox2+ endoderm progenitors are regulated by both
common and distinct Hdac1/2-mediated pathways during
development and postnatal tissue regeneration.
Sox2+ is a critical transcription factor important for tissue-
specific progenitors in multiple organs. In the lung, Sox2 is
essential for development of the entire proximal airway epithelial
lineage repertoire. Despite its criticality, little is understood about
how Sox2 expression is initiated or maintained during develop-
ment. Our finding that Hdac1/2 regulates Sox2 expression in
the proximal airway epithelium of the developing respiratoryDevelopmsystem but not the esophagus suggests that its expression is
differentially regulated in a tissue-specific fashion. This may be
due to the unique requirements of Bmp signaling activity in the
anterior foregut endoderm. Previous studies have shown that
Bmp signaling is necessary for initial development of the trachea
and that its signaling activity inhibits Sox2 expression (Domyan
et al., 2011). How this precise activity is initiated and maintained
has been unclear, but our data now show that inhibition of Bmp4
expression allows for the proper development of the proximal
component of the respiratory system. In this manner, we postu-
late that Hdac1/2 act as critical repressive chromatin remodeling
factors for establishing proximal lung progenitor cell fate, in part,
through inhibition of Bmp4.
Additional evidence indicates that Bmp4 may be a nodal point
for Hdac-mediated repression and regulation of tissue develop-
ment through Sox2 expression. Trichostatin A, an inhibitor of
class I Hdacs, increases Bmp4 expression in limb bud explants
(Zhao et al., 2009). Moreover, increased Bmp4 expression leads
to decreased Sox2 expression in the neural tube (Linker and
Stern, 2004). The specific effect that loss of Hdac1/2 have on
the proximal component of the respiratory system without
apparent effects on esophageal development may be due to
this unique targeting of Bmp4 signaling.
Hdac1/2 have been shown to regulate cell-cycle progression
through derepression of p16/Ink4a and p21/Cdkn1a (Wilting
et al., 2010; Yamaguchi et al., 2010). However, given the potent
inhibition of cell proliferation often observed upon loss of
Hdac1/2 in multiple tissues, including the lung, as well as theental Cell 24, 345–358, February 25, 2013 ª2013 Elsevier Inc. 353
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Figure 6. Hdac1/2 Are Necessary for Regeneration of Sox2+ Airway Epithelium
(A) Napthalene-induced injury of the airways leads to depletion of the majority of secretory cells in the bronchiolar region of the lung with regeneration of the
secretory lineage complete by 1 month after injury.
(B–E) Immunostaining for Scgb1a1 (B and C) and Sox2 (D and E) shows the severe loss in secretory epithelial cells 4 days postinjury in both Scgb1a1cre and
Hdac1/2Scgb1a1creDKO mutants.
(F) Ten days postinjury, Scgb1a1+/Sox2+ secretory cells in the airways of the lung have not regenerated in Hdac1/2Scgb1a1creDKO mutants, whereas Scgb1a1cre
controls have regenerated normally.
(G) Quantitative real-time PCR shows a dramatic loss in Scgb1a1, Sox2, and Scgb3a2 expression with a much smaller loss in TubbIV expression 10 days
postinjury.
(H) At 1 month postinjury, Hdac1/2Scgb1a1creDKO mutants continue to lack regeneration of Scgb1a1+/Sox2+ secretory epithelium.
(I) Quantitative real-time PCR at 1 month postinjury confirms decreased Scgb1a1, Sox2, and Scgb3a2 expression, whereas TubbIV expression is unchanged (I).
Quantitative real-time PCR data shown are the average of three to five assays ± SEM. Scale bars represent 20 mm in (C), (E), and (F) and 40 mm in (H). See also
Figure S4.
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Figure 7. Hdac1/2 Promote Airway Epithelial Regeneration through Regulation of Cell-Cycle Regulators Rb1, p21/Cdkn1a, and p16/Ink4a
(A) Cell proliferation as measured by Ki67 immunostaining is reduced by more than 80% during the airway epithelial regeneration process from days 4–10 in
Hdac1/2Scgb1a1creDKO mutants.
(B) Quantification of Ki67+ cells against total bronchiolar epithelial cells in both control and Hdac1/2Scgb1a1creDKO lungs.
(C–H) Rb1 (C and D), p21/Cdkn1a (E and F), and p16/Ink4a (G and H) expression levels are upregulated during the process of airway regeneration in Hdac1/
2Scgb1a1creDKO lungs.
(legend continued on next page)
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HDAC1/2 Control Lung Development and Regenerationinability of loss of p16/Ink4a and p21/Cdkn1a to reduce Hdac1/
2-mediated inhibition of cell proliferation, additional factors are
likely involved (Wilting et al., 2010). Our studies have identified
Rb1 as a target of Hdac1/2 in the regulation of the cell cycle in
lung endoderm. Rb1 is a well-known tumor suppressor
whose aberrant silencing is closely associated with lung cancer
(Ding et al., 2008; Sutherland et al., 2011). Rb1 and Hdac1
have been reported to physically interact (Brehm et al., 1998;
Magnaghi-Jaulin et al., 1998), but whether Rb1 was a direct
transcriptional target of Hdac activity was previously not
known. Our studies demonstrate that Rb1 is a direct target of
Hdac1/2-mediated repression and that its derepression is
associated with decreased proliferation. Unlike Bmp4, Rb1 is
also upregulated in Hdac1/2-deficient postnatal lung epithelium
during the process of lung epithelial regeneration. This increased
expression of Rb1 and other cell-cycle inhibitors, including p16/
Ink4a and p21/Cdkn1a, leads to a dramatic inhibition of the
regenerative capacity of the airway epithelium after naphtha-
lene-induced depletion. Our results suggest that Bmp4 is
a unique target of Hdac1/2 during lung development, whereas
Rb1-mediated cell-cycle inhibition is a common Hdac1/2-regu-
lated pathway that is shared during both lung development
and regeneration.
The potent role for Hdac1/2 in regulating airway epithelial
regeneration is interesting in light of recent findings showing
that decreased HDAC activity, and in particular HDAC2 expres-
sion, is associated with the severity of disease in COPD patients
(Ito et al., 2005, 2006). COPD is a spectrum of lung diseases that
is represented by progressive lung airway obstructions caused
by environmental irritants, such as tobacco smoking. Although
cigarette smoke-triggered inflammation has received much
attention as a cellular and molecular mechanism of COPD, the
inappropriate airway repair and regeneration after repeated
insults by smoking is also thought to play an important role.
Exposure to cigarette smoke can induce cellular senescence in
the mouse lung (Nyunoya et al., 2006, 2009), suggesting the
potential role of impaired cell proliferation in response to airway
injuries in the progression of the disease. Our findings indicate
that Hdac1/2 act to allow for the proper reactivation of cell-cycle
progression in the regenerating airway epithelium after injury
through repression of Rb1 as well as other cell-cycle regulators,
including p16/Ink4a and p21/Cdkn1a. It is important to note that
although we did not observe a deficiency in naphthalene-
induced regeneration in Hdac2-deficient animals (data not
shown), the naphthalene model of secretory cell depletion and
regeneration is not a recapitulation of human COPD but rather
represents an acute injury and regeneration process. Nonethe-
less, it is conceivable that the more chronic injury and repair
process that underlies human exposure to smoke and other
pollutants may lead to a progressive degradation in the ability
of HDAC2-deficient airway epithelium to successfully regen-
erate. Our data suggest that small molecule therapies that alter
the balance of histone acetylation may prove useful in treatment
of lung diseases such as COPD.(I) A model for Hdac1/2 action during both lung development and postnatal airwa
proximal lung progenitor development and promotes Sox9+ distal progenitor dev
during development and lung regeneration.
Cell counting data shown are the average of three to four samples ± SEM. Scale
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Additional details on the Experimental Procedures can be found in the Supple-
mental Experimental Procedures.
Microarray Analysis
RNA was isolated from E12.5 lungs from Shhcre control and Hdac1/2ShhCreDKO
embryos. For each sample, six lung buds were collected and pooled. The RNA
was then used to generate a biotinylated cRNA probe library for Affymatrix
Mouse Gene 1.0ST array. Microarray data were analyzed using the Oligo
package available at the Bioconductor website (http://www.bioconductor.
org). The raw data were background-corrected by the Robust Multichip
Average (RMA) method and then normalized by an invariant set method.
Differential gene expression between the control and mutant mice was
analyzed by the Limma package available at the Bioconductor website.
p values obtained from the multiple comparison tests were corrected by
false discovery rates. Heatmap displays were created using the freely available
MeV package (http://www.tm4.org/mev/). See Table S1 for the list of genes
that were significantly altered. The microarray data have been deposited into
the Gene Expression Omnibus database, and the accession number is
GSE39946.
Quantitative Real-Time PCR
Total RNA was isolated from lungs at indicated time points using an RNeasy
Mini Kit (QIAGEN, Hilden, Germany). cDNA was synthesized from total RNA
by using SuperScript Strand Synthesis System (Invitrogen, Carlsbad, CA,
USA). Quantitative PCRwas performed using the SYBR green system (Applied
Biosystems, Foster City, CA, USA) with primers listed in the Supplemental
Experimental Procedures. GAPDH expression values were used to control
for RNA quality and quantity. Five to six lungs were used for each embryonic
lung quantitative real-time PCR experiment, and three to five lungs were
used for each adult lung quantitative real-time PCR experiment, and data
shown are the average ± SEM.
ChIP Assays
For ChIP assays on Hdac1/2 antibodies, at least 15 E12.5 lung buds were
dissected and crosslinked by 3.7% formaldehyde. Crosslinked tissue was
sonicated to obtain genomic DNA fragments between 200–400 bp. Chromatin
was prepared using a ChIP Assay Kit (Millipore, Billerica, MA, USA). ChIP anti-
bodies (Hdac1 and Hdac2; Abcam, Cambridge, UK) were used to precipitate
the Hdac1/2 bound regions, which were then detected and quantified by PCR
and quantitative real-time PCR with primers listed in the Supplemental Exper-
imental Procedures. Rabbit IgG was used as a negative control antibody in
these assays. The region of the Bmp4 promoter corresponds to approximately
400 bp upstream of the transcriptional start site, whereas the region of the Rb1
promoter corresponds to approximately 700 bp upstream of the Rb1 tran-
scriptional start site. For ChIP assays using H3K9 acetylation antibodies
(Abcam), MLE12 cells were transfected with control or Hdac1/2 siRNA
(Dharmacon, Lafayette, CO, USA) and harvested after 48 hr to generate chro-
matin. E11.5 lung buds were cultured with or without 50nM TSA for 24 hr
before harvesting to generate chromatin.
Lung Explant Culture
E11.5 lung buds were dissected from the embryos and then cultured as
previously described (Goss et al., 2011) in the presence of either 500 ng/ml
recombinant Bmp4 or BSA medium for 48 hr. The lung buds were then fixed
in 2% PFA for histology or stored for RNA extraction.
Naphthalene Injury
Adult mice of 8- to 10-weeks-old were injected intraperitoneally with
250 mg/kg body weight of naphthalene dissolved in corn oil as previously
described (Li et al., 2012). At indicated time points after injection, the righty epithelial regeneration. Hdac1/2 inhibits Bmp4, which in turn inhibits Sox2+
elopment. Hdac1/2 also regulates Rb1, which inhibits endoderm proliferation
bars represent 10 mm. See also Figure S5.
ier Inc.
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HDAC1/2 Control Lung Development and Regenerationlung lobe was collected for RNA extraction, and left lobes were inflation fixed
with 10% formalin for histological sections. Scgb1a1cre mice were used as
control mice.SUPPLEMENTAL INFORMATION
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